A phase I/II study of idarubicin, dexamethasone and interferon-α (I-Dexa) in patients with relapsed or refractory multiple myeloma

Leukemia

Volumn 11, Issue SUPPL. 5, 1997, Pages

  Hubel, K ^a   Tesch, H ^a   Kroger, B ^a   Schnell, R ^a   Borchmann, P ^a   Diehl, V ^a   Engert, A ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Dexamethasone; Idarubicin; Interferon ; Multiple myeloma; Relapse

Indexed keywords

ALPHA INTERFERON; DEXAMETHASONE; IDARUBICIN; RECOMBINANT ALPHA2A INTERFERON;

ADULT; AGED; ANEMIA; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; LEUKOPENIA; MALE; MULTIPLE MYELOMA; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA;

EID: 0031474447     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)